Literature DB >> 6754515

Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.

R A DeFronzo, D Simonson, E Ferrannini.   

Abstract

Hepatic glucose production (3H-glucose technique) and insulin-mediated glucose uptake (insulin clamp technique) were measured in 38 Type 2 (non-insulin-dependent) and 11 Type 1 (insulin-dependent) diabetic patients. Fasting plasma glucose concentration was 8.3 +/- 0.5 mmol/l in the former, and 9.6 +/- 1.3 mmol/l in the latter group; the respective fasting plasma insulin levels were 19 +/- 2 mU/l (p less than 0.005 versus 13 +/- 1 mU/l in 33 age-matched control subjects), and 9 +/- mU/l (p less than 0.01 versus 14 +/- 1 mU/l in 36 younger control subjects). In the fasting state, hepatic glucose production was slightly increased (15%, 0.1 greater than p greater than 0.05) in the Type 2 diabetic patients and markedly elevated (65%, p less than 0.001) in the Type 1 patients compared with their respective control groups. In both groups of diabetic subjects, the rates of hepatic glucose production were inappropriately high for the prevailing plasma glucose and insulin levels, indicating the presence of hepatic resistance to insulin. Basal plasma glucose clearance was also significantly reduced in both the Type 2 (34%) and the Type 1 (14%) diabetic subjects. The fasting plasma glucose concentration correlated directly with hepatic glucose production, and inversely with plasma glucose clearance. During the insulin clamp, plasma insulin was maintained at approximately 100 mU/l in all groups, while plasma glucose was maintained constant at the respective fasting levels. Total glucose uptake was reduced in both the Type 2 (4.57 +/- 0.31 versus 6.39 +/- 0.25 mg . min -1 . kg -1 in the control subjects, p less than 0.01) and the Type 1 (4.77 +/- 0.48 versus 7.03 +/- 0.22 mg . min -1 . kg -1, p less than 0.01)diabetic patients. Insulin-stimulated glucose clearance was reduced to a similar extent in Type 2 (54%) and Type 1 (61%) diabetic subjects, and correlated directly with fasting glucose clearance. These results show that insulin resistance is a common feature of both types of diabetes and can be demonstrated in the basal as well as the insulin-stimulated state. Both hepatic and peripheral resistance to the action of insulin contribute to diabetic hyperglycaemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754515     DOI: 10.1007/bf00253736

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Insulin concentrations in portal venous and peripheral venous blood in man following administration of glucose, galactose, xylitol and tobutamide.

Authors:  W Berger; H Göschke; J Moppert; H Künzli
Journal:  Horm Metab Res       Date:  1973-01       Impact factor: 2.936

2.  Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica.

Authors:  G Rosselin; R Assan; R S Yalow; S A Berson
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

3.  Glucose turnover and disposal in maturity-onset diabetes.

Authors:  H F Bowen; J A Moorhouse
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

4.  Glucose intolerance and aging: evidence for tissue insensitivity to insulin.

Authors:  R A Defronzo
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

5.  Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity.

Authors:  Y Harano; S Ohgaku; H Hidaka; K Haneda; R Kikkawa; Y Shigeta; H Abe
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

6.  Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion.

Authors:  Y Harano; S Ohgaku; K Kosugi; H Yasuda; T Nakano; M Kobayashi; H Hidaka; K Izumi; A Kashiwagi; Y Shigeta
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

7.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.

Authors:  R DeFronzo; D Deibert; R Hendler; P Felig; V Soman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Determination of free and total insulin and C-peptide in insulin-treated diabetics.

Authors:  H Kuzuya; P M Blix; D L Horwitz; D F Steiner; A H Rubenstein
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

9.  Investigation of insulin sensitivity in treated subjects with ketosis-prone diabetes mellitus.

Authors:  H N Ginsberg
Journal:  Diabetes       Date:  1977-04       Impact factor: 9.461

10.  Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects.

Authors:  L C Harrison; F I Martin; R A Melick
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more
  128 in total

Review 1.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

2.  Natural vanadium-containing Jeju ground water stimulates glucose uptake through the activation of AMP-activated protein kinase in L6 myotubes.

Authors:  Seung-Lark Hwang; Hyeun Wook Chang
Journal:  Mol Cell Biochem       Date:  2011-09-23       Impact factor: 3.396

Review 3.  Fuel selection and carbon flux during the starved-to-fed transition.

Authors:  M C Sugden; M J Holness; T N Palmer
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

4.  Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes.

Authors:  Jill A Bell; Elena Volpi; Satoshi Fujita; Jerson G Cadenas; Melinda Sheffield-Moore; Blake B Rasmussen
Journal:  J Nutr       Date:  2006-05       Impact factor: 4.798

Review 5.  Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status.

Authors:  M B Davidson
Journal:  West J Med       Date:  1985-02

6.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Characterization of insulin resistance in type I diabetes.

Authors:  W Kerner; I Navascués; T von Schrenck; R Fussgänger; P Arias; E F Pfeiffer
Journal:  Klin Wochenschr       Date:  1985-06-18

8.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Authors:  C Bogardus; S Lillioja; B V Howard; G Reaven; D Mott
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats.

Authors:  Aleksey V Matveyenko; Johannes D Veldhuis; Peter C Butler
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

10.  Basal insulin resistance and secretion in Nigerians with type 2 diabetes mellitus.

Authors:  J M Oli; A A Adeyemo; G O Okafor; E N Ofoegbu; B Onyenekwe; C J Chukwuka; C N Onwasigwe; S Ufelle; G Chen; C N Rotimi
Journal:  Metab Syndr Relat Disord       Date:  2009-12       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.